Felicity Savage

Felicity Savage is a Senior Lecturer in Life Sciences at Anglia Ruskin University's Faculty of Science and Engineering, Cambridge campus. Her teaching spans undergraduate Levels 3-6 across biochemistry, cell biology, histology, physiology, mathematics, and specialized cancer biology/orthopaedic science modules. She emphasizes practical skills development and academic writing through dedicated tutorials, serving as Course Leader for the BSc (Hons) Biomedical Science with Foundation Year program and Module Leader for Foundation Maths for Science.

Her academic qualifications include:

• PhD in Inflammatory Bowel Disease from Liverpool Polytechnic
• BSc in Biochemistry from UMIST

Dr. Savage's research program investigates molecular mechanisms in gastrointestinal pathologies, with three core pillars: (1) Matrix metalloproteinase regulation in colonic wound healing under compromised conditions, (2) Endothelin signaling pathways in colorectal cancer progression and therapeutic targeting, and (3) Molecular analysis of inflammatory bowel disease using rabbit models. Her work bridges surgical outcomes, cancer metastasis mechanisms, and connective tissue degradation processes through tissue analysis and preclinical models.

Analysis of her 15 most recent publications reveals sustained expertise in gastrointestinal molecular pathology across three decades. The corpus demonstrates methodological evolution from foundational biochemical analyses to translational preclinical studies, with consistent focus on matrix metalloproteinase systems and endothelin receptor pharmacology. Key trends include progression from descriptive enzyme distribution studies to functional therapeutic investigations, particularly regarding endothelin antagonists in cancer treatment and surgical complication prevention.

As an academic supervisor, Dr. Savage has guided numerous PhD, MD, and MSc students through research on colonic anastomotic healing, inflammatory bowel disease modeling, and colorectal cancer cell behavior. She actively contributes to the Biomedical Research Group, where her current work explores surgical intervention impacts on cancer recurrence through cellular spillage mechanisms and develops molecular-targeted therapeutic strategies.